1 patient with grade 1 paresthesia, which was ongoing from day 18 to time of withdrawal from study at 4.7 months post infusion *Presented by YC Cohen at the 2nd International Myeloma Society IMS) Annual Meeing & Exposition: September 1720, 2025; Toronto, ON, Canada. CARTITUDE-4 (Australia, Austria, Belgium, Denmark, France, Germany, Italy,Israel, Japan, Republic of Korea, Netherlands, Poland, Spain, Sweden, United Kingdom, United States)
原图定位
